Effect Observation of Psoriasis Capsule and Compound Glycyrrhizin for Plaque Psoriasis Vulgaris
Objective To analyze clinical effect of psoriasis capsule and compound glycyrrhizin for plaque psoriasis vulgaris.Methods Methods:a total of 90 patients with plaque psoriasis vulgaris in our hospital from January 2021 to November 2022 were selected.45 cases were divided into the control group(compound glycyrrhizin)and the remaining 45 cases were divided into the observation group(Yinxie capsule was added on the basis of the former group).The curative effect,skin state changes after treatment,pruritus,hypertrophy,skin lesion color score and the incidence of side effects were compared between the two groups.Results:Effective rate in observation group(95.56%)was higher than control group(80.00%)(P<0.05).Before treatment,BSA,DLQI and PASI scores between observation group and control group were not significantly different(P>0.05).After treatment,BSA,DLQI and PASI scores in observation group were lower than control group(P<0.05).Before treatment,skin pruritus,pachyderma,skin damage and color symptom scores between observation group and control group were not significantly different(P>0.05).After treatment,skin pruritus,pachyderma,skin damage and color symptom scores in observation group were lower than control group(P<0.05).There were no significant between-group difference in side reactions like skin edema,hypokalemia,hepatic and renal damage,nausea and vomiting(P>0.05).Conclusion Psoriasis capsule and compound glycyrrhizin can reduce clinical symptoms with less adverse reactions,increase life quality and treatment safety of plaque psoriasis vulgaris patients,which is worthy of clinical application.